Prosecution Insights
Last updated: October 01, 2026

University of Utah Research Foundation

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

48 pending office actions • 34 art units • 48 examiners • 0 of 48 (0%) have an AI response strategy ready • 38 patents granted in the last 365 days

Analysis

The University of Utah Research Foundation manages a patent portfolio within the Biotechnology & Pharmaceuticals technology area. There are currently 48 pending office actions, which are distributed among 48 distinct examiners. This distribution indicates a prosecution landscape where no single examiner oversees multiple pending cases.

The portfolio's activity spans 34 distinct art units, reflecting a range of specialized technical subject matter within the life sciences. Baisakhi Roy is the busiest examiner currently associated with the foundation, though this individual is only responsible for 1 pending office action. With 48 total actions across 34 art units, the foundation interacts with a variety of USPTO departments. This diversity in examiners and art units requires managing responses across many different examiner preferences and art unit standards.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

48
Total Pending OAs
29
Non-Final OAs
19
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 17 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

13
Overdue
1
Due this week
1
Due this month
2
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 17 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (13)Due ≤ 7 days (1)Due ≤ 30 days (1)Due ≤ 60 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

20
Hard (42%)
23
Medium (48%)
5
Easy (10%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (2%)
§101 + other5 (10%)
§103 only15 (31%)
§102 only3 (6%)
§112 only4 (8%)
Double-patenting only1 (2%)
Double-patenting + other5 (10%)
Multi-statute (no §101)14 (29%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

27
Life Sciences
56% of docket
0
Information Tech
0% of docket
1
Communications
2% of docket
0
Semiconductors
0% of docket
11
Mechanical / Eng
23% of docket
9
Business / Other
19% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

480 h
Manual time on pending OAs
96 h
Time saved (low, 20%)
168 h
Time saved (mid, 35%)
4.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ROY, BAISAKHI 1 77.7% +18.7%
BRUTUS, JOEL F 1 72.8% +17.7%
YANG, ANDREW 1 84.3% +10.5%
ALI, SHAWKAT M 1 89.1% +20.5%
MATTHEWS, MADISON ROSE 1 80.4% +34.8%
JASANI, ASHISH SHIRISH 1 68.6% +25.1%
ROE, JESSEE RANDALL 1 76.4% +7.8%
ABDUR, RAHMAN 1 74.0% +17.8%
WILLSE, DAVID H 1 67.3% +13.7%
ALAOUIE, ALI MUSTAFA 1 — —

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18968893 TRAUMA GURNEY WITH ENHANCED PATIENT TRANSFER CAPABILITIES MATTHEWS, MADISON ROSE 18d overdue

Hard Cases (20)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17625866 CLOSTRIDIA CONSORTIA COMPOSITIONS AND METHODS OF TREATING OBESITY, METABOLIC SYNDROME AND IRRITABLE BOWEL DISEASE ESPINOSA, CLAUDIA EDILMA 60d overdue
17920695 Implantable Transition Micro-Electrodes MINCHELLA, ADAM ZACHARY 45d overdue
17929062 ASSESSMENT OF MELANOMA THERAPY RESPONSE GRAY, JESSICA 44d overdue
18117316 ELECTRIC GRIP GAUGE FOR ASSESSING HAND DEXTERITY EISEMAN, ADAM JARED 8d overdue
18875819 CARTILAGE AND BONE HARVEST AND DELIVERY SYSTEM AND METHODS YANG, ANDREW 2d overdue
17796494 HIGH MOLECULAR WEIGHT HEPARIN COMPOSITIONS AND METHODS FOR DIAGNOSING, TREATING AND MONITORING EOSINOPHIL MEDIATED INFLAMMATORY DISEASES MEJIAS, SAMANTHA LEE 2d overdue
17801002 METHODS FOR REHABILITATING HEART FAILURE USING GENE THERAPY AFREMOVA, VERA 7d
19262345 CARDIAC TISSUE CHARACTERIZATION USING CATHETERIZED LIGHT SCATTERING SPECTROSCOPY ROY, BAISAKHI —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18968893 TRAUMA GURNEY WITH ENHANCED PATIENT TRANSFER CAPABILITIES MATTHEWS, MADISON ROSE 18d overdue
18875819 CARTILAGE AND BONE HARVEST AND DELIVERY SYSTEM AND METHODS YANG, ANDREW 2d overdue
18869772 SYSTEM AND METHOD FOR SHARPENING THE FOCAL VOLUME OF THERAPEUTIC AND IMAGING SYSTEMS JASANI, ASHISH SHIRISH 34d
19262345 CARDIAC TISSUE CHARACTERIZATION USING CATHETERIZED LIGHT SCATTERING SPECTROSCOPY ROY, BAISAKHI —
19244668 IMPLANTABLE AND BIODEGRADABLE SMART HYDROGEL MICROMECHANICAL RESONATORS WITH ULTRASOUND READOUT BRUTUS, JOEL F —
18874421 A WIDE-BAND, MULTI-PHASE PHASE-LOCKED LOOP CIRCUIT ALI, SHAWKAT M —
18797238 SYSTEM AND METHOD FOR QUANTITATIVE PHASE IMAGING FOR MULTI-PARAMETRIC SCREENING OF TUMOR THERAPY RESPONSE ABDUR, RAHMAN —
18774524 Variable Transmission For Assistive Prosthesis Device WILLSE, DAVID H —

Top Art Units

Art UnitApps
3775 2
1642 2
1675 2
1682 2
1654 2
3797 1
2633 1
3673 1
3798 1
1759 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19262345 CARDIAC TISSUE CHARACTERIZATION USING CATHETERIZED LIGHT SCATTERING SPECTROSCOPY ROY, BAISAKHI — §103§112 Non-Final OA — Pending Jul 08, 2025
19244668 IMPLANTABLE AND BIODEGRADABLE SMART HYDROGEL MICROMECHANICAL RESONATORS WITH ULTRASOUND READOUT BRUTUS, JOEL F 3797 §103Other Non-Final OA — Pending Jun 20, 2025
18875819 CARTILAGE AND BONE HARVEST AND DELIVERY SYSTEM AND METHODS YANG, ANDREW 3775 §101§102§103Other Non-Final OA 2d overdue Pending Dec 17, 2024
18874421 A WIDE-BAND, MULTI-PHASE PHASE-LOCKED LOOP CIRCUIT ALI, SHAWKAT M 2633 §103§112 Non-Final OA — Pending Dec 12, 2024
18968893 TRAUMA GURNEY WITH ENHANCED PATIENT TRANSFER CAPABILITIES MATTHEWS, MADISON ROSE 3673 §103 Final Rejection 18d overdue Pending Dec 04, 2024
18869772 SYSTEM AND METHOD FOR SHARPENING THE FOCAL VOLUME OF THERAPEUTIC AND IMAGING SYSTEMS JASANI, ASHISH SHIRISH 3798 §103 Final Rejection 34d Pending Nov 26, 2024
18819806 Thermo-Hydrogen Refinement of Microstructure of Titanium Materials ROE, JESSEE RANDALL 1759 §103§112Other Final Rejection — Pending Aug 29, 2024
18797238 SYSTEM AND METHOD FOR QUANTITATIVE PHASE IMAGING FOR MULTI-PARAMETRIC SCREENING OF TUMOR THERAPY RESPONSE ABDUR, RAHMAN — §102§103 Non-Final OA — Pending Aug 07, 2024
18774524 Variable Transmission For Assistive Prosthesis Device WILLSE, DAVID H — §112 Non-Final OA — Pending Jul 16, 2024
18744116 COMPOSITIONS AND METHODS FOR TREATING SIALORRHEA ALAOUIE, ALI MUSTAFA — §103§112DP Non-Final OA — Pending Jun 14, 2024
18702311 PRE-LIBRARY TARGET ENRICHMENT FOR NUCLEIC ACID SEQUENCING GROSS, CHRISTOPHER M — §102§103§112 Non-Final OA — Pending Apr 17, 2024
18687723 HYBRIDIZATION PROBES CONTAINING FLUORINATED CARBON CHAINS AND RELATED METHODS RILEY, JEZIA — §102 Non-Final OA — Pending Feb 28, 2024
18444305 COMPOSITIONS AND METHODS OF USE FOR HUMAN RHINOVIRUSES ALAM, DANYAL HASSAN 1633 §101§102§112 Non-Final OA — Pending Feb 16, 2024
18573350 COMPOSITIONS AND METHODS FOR TREATING PGM1 DEFICIENCY GROOMS, TIFFANY NICOLE — §103 Non-Final OA — Pending Dec 21, 2023
18537497 THREE-DIMENSIONAL PERCOLATION ARRAY STRUCTURE AS A GAS SENSOR HANDY, DWAYNE K — §102§103Other Non-Final OA — Pending Dec 12, 2023
18567010 SELECTIVE PENICILLAMINE SUBSTITUTION ENABLES DEVELOPMENT OF A POTENT ANALGESIC PEPTIDE THAT ACTS THROUGH A NON-OPIOID BASED MECHANISM REYNOLDS, FRED H 1658 §102§103§112DP Non-Final OA — Pending Dec 04, 2023
18527086 DRUG-ELUTING SUTURE FOR ATTENUATING INFLAMMATION IN WOUNDS ALAM, AYAAN A 1611 §103§112 Final Rejection — Pending Dec 01, 2023
18494072 METHODS FOR FAST NUCLEIC ACID AMPLIFICATION HORLICK, KENNETH R 1681 DP Final Rejection 17d overdue Pending Oct 25, 2023
18375485 CANNULATED CONTINUOUS COMPRESSION SCREW COLEY, ZADE JAMES 3775 §103 Non-Final OA — Pending Sep 30, 2023
18546258 TREATMENT OF MYOPIA HUANG, GIGI GEORGIANA 1613 §103DP Non-Final OA 21d Pending Aug 11, 2023
18262522 PNMA2-BASED CAPSIDS AND USES THEREOF BARRERA, IMMACULADA 1671 §103 Final Rejection — Pending Jul 21, 2023
18352014 POLYESTER NETWORKS FROM STRUCTURALLY SIMILAR MONOMERS: RECYCLABLE-BY-DESIGN AND UPCYCLABLE TO PHOTOPOLYMERS RUNYAN, SILVANA C 3674 §103 Non-Final OA — Pending Jul 13, 2023
18212168 BIOHAZARD ANALYZER LUSI, ELLIS FOLLETT 1672 §103§112 Non-Final OA — Pending Jun 20, 2023
18328609 OCULAR TISSUE SAMPLING DEVICE GERHARD, ALISON CLAIRE 1797 §103 Non-Final OA — Pending Jun 02, 2023
18328456 Inerter-Based Elastic Metamaterials For Low-Frequency Vibration Mitigation SAHNI, VISHAL R 3616 §103 Final Rejection — Pending Jun 02, 2023
18324773 Zwitterion Polymer-Drug Conjugates MOSELEY II, NELSON B 1642 §102§103 Non-Final OA — Pending May 26, 2023
18196932 DYNAMIC CELL CULTURE PLATFORM FOR COMBINATORIAL AND BIOMECHANICAL STIMULATION CARREON, ADRIAN JOHN 1799 §102§103 Final Rejection — Pending May 12, 2023
18315999 HIGH-EFFICIENCY ELECTROLYSIS OF IRON ORE FOR IRON PRODUCTION MENDEZ, ZULMARIAM 1794 §102§103 Final Rejection — Pending May 11, 2023
18033052 Volitional Walking Controller HU, ANN M 3774 §102 Non-Final OA — Pending Apr 20, 2023
18117316 ELECTRIC GRIP GAUGE FOR ASSESSING HAND DEXTERITY EISEMAN, ADAM JARED 3791 §102§103 Non-Final OA 8d overdue Pending Mar 03, 2023
18043792 SYSTEMS AND METHODS FOR CONTROLLING BACTERIAL TRANSCRIPTION REGA, KYLE THOMAS 1636 §103 Final Rejection 5d overdue Pending Mar 02, 2023
18173680 Compositions and Methods for Killing PD-1 Positive Cells BERHANE, SELAM 1675 §112 Final Rejection 40d Pending Feb 23, 2023
18010580 BIOMARKER BASED PATIENT SELECTION FOR PROTEASOME INHIBITOR TREATMENT AEDER, SEAN E 1642 §102 Non-Final OA — Pending Dec 15, 2022
17920695 Implantable Transition Micro-Electrodes MINCHELLA, ADAM ZACHARY 3794 §102§103 Final Rejection 45d overdue Pending Oct 21, 2022
17963119 MULTI-SEQUENCE CAPTURE SYSTEM ZHANG, KAIJIANG 1684 §112 Non-Final OA — Pending Oct 10, 2022
17929062 ASSESSMENT OF MELANOMA THERAPY RESPONSE GRAY, JESSICA 1682 §101§103§112 Final Rejection 44d overdue Pending Sep 01, 2022
17900240 IMPLANTABLE BONE SCAFFOLDS INCLUDING AT LEAST ONE INTEGRATION AID, METHODS OF MAKING AND USING THE SAME LIU, TRACY 1614 §103DP Non-Final OA 35d overdue Pending Aug 31, 2022
17801002 METHODS FOR REHABILITATING HEART FAILURE USING GENE THERAPY AFREMOVA, VERA 1653 §102§103 Final Rejection 7d Pending Aug 19, 2022
17796494 HIGH MOLECULAR WEIGHT HEPARIN COMPOSITIONS AND METHODS FOR DIAGNOSING, TREATING AND MONITORING EOSINOPHIL MEDIATED INFLAMMATORY DISEASES MEJIAS, SAMANTHA LEE 1618 §101§103§112 Non-Final OA 2d overdue Pending Jul 29, 2022
17776563 OPTIDICER CONSTRUCT FOR AGE-RELATED MACULAR DEGENERATION MONTANARI, DAVID A 1632 §112 Final Rejection 66d overdue Pending May 12, 2022
17724296 METHODS AND SYSTEMS FOR MULTIPLE TAXONOMIC CLASSIFICATION WOITACH, JOSEPH T — §101§103Other Non-Final OA — Pending Apr 19, 2022
17766489 TARGETED SEQUENCING TO DETECT AND QUANTIFY LOW LEVELS OF METHYLATED DNA DAUNER, JOSEPH G 1682 §103 Final Rejection — Pending Apr 04, 2022
17640627 COMPOSITIONS AND METHODS FOR USING SILK-ELASTINLIKE PROTEIN-BASED POLYMERS FONTAINHAS, AURORA M 1675 §103 Final Rejection 113d overdue Pending Mar 04, 2022
17626469 MULTI-AGENT OCULAR FORMULATIONS AND TREATMENT METHODS PIPIC, ALMA 1617 §103Other Final Rejection — Pending Jan 11, 2022
17625866 CLOSTRIDIA CONSORTIA COMPOSITIONS AND METHODS OF TREATING OBESITY, METABOLIC SYNDROME AND IRRITABLE BOWEL DISEASE ESPINOSA, CLAUDIA EDILMA 1654 §101 Final Rejection 60d overdue Pending Jan 10, 2022
17616111 NOVEL LIVE-CELL ASSAY FOR NEURONAL ACTIVITY NICOL, ALEXANDER W 1634 §103 Non-Final OA 2d overdue Pending Dec 02, 2021
17528853 MICRO-MOLDED ELECTRODES, ARRAYS, AND METHODS OF MAKING THE SAME CAZAN, LIVIUS RADU 3729 §103 Non-Final OA — Pending Nov 17, 2021
17348694 DIMERIC COLLAGEN HYBRIDIZING PEPTIDES AND METHODS OF USE THEREOF SABILA, MERCY HELLEN 1654 §102§112DP Non-Final OA — Pending Jun 15, 2021

Managing University of Utah Research Foundation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month